番茄社区app

Continued OAC failed to meet noninferiority in POPular PAUSE TAVI

Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival

NOTION-3 trial informs care for those with severe AS and stable CAD

RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates

Randomized trial "highly encouraging" for making patients feel and function better

Either choice is "acceptable" based on randomized study

RNA silencer impresses with results in transthyretin amyloidosis cardiomyopathy

ACE-PROTAVI trial tested upfront vs selective use of heparin reversal agent

Report is part of larger efforts to increase awareness of neglected disease

Eight decades after FDR's decline and death, do White House physicians owe truth to the public?

Three regimens compared head-to-head among abundant choices

Most cases were mild, and age was a predictor of disease

Question of clinical benefit beyond LVEF improvement will require larger trials

New additions to Sapien, Evolut, Navitor lines aim to ensure coronary access